ROCKWELL MEDICAL, INC. Investment Income, Interest
ROCKWELL MEDICAL, INC. (RMTI) reported Investment Income, Interest of $211.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-21.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2024-03-21
- ROCKWELL MEDICAL, INC. investment income, interest for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. investment income, interest for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. investment income, interest for the quarter ending 2021-12-31 was $5.00K.
- ROCKWELL MEDICAL, INC. investment income, interest for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. investment income, interest for fiscal 2023 was $211.00K, a 539.39% increase from fiscal 2022.
- ROCKWELL MEDICAL, INC. investment income, interest for fiscal 2022 was $33.00K, a 50.00% increase from fiscal 2021.
- ROCKWELL MEDICAL, INC. investment income, interest for fiscal 2021 was $22.00K, a 90.76% decline from fiscal 2020.
- ROCKWELL MEDICAL, INC. investment income, interest for fiscal 2020 was $238.00K, a 39.29% decline from fiscal 2019.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $211.00K 10-K · filed 2024-03-21 | |||||
| 2022-12-31 | $33.00K 10-K · filed 2024-03-21 | |||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | -$4.00K 10-Q · filed 2022-08-15 | $5.00K derived: sum of 3 quarters · filed 2023-03-30 | $5.00K derived: sum of 4 quarters · filed 2023-03-30 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | $5.00K derived: sum of 2 quarters · filed 2023-03-30 | $5.00K derived: sum of 3 quarters · filed 2023-03-30 | $12.00K derived: sum of 4 quarters · filed 2023-03-30 | ||
| 2021-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $5.00K derived: sum of 2 quarters · filed 2023-03-30 | $12.00K derived: sum of 3 quarters · filed 2023-03-30 | $22.00K 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | $7.00K derived: sum of 2 quarters · filed 2022-08-15 | $17.00K 10-Q · filed 2021-11-15 | $17.00K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-06-30 | $7.00K 10-Q · filed 2022-08-15 | $18.00K 10-Q · filed 2022-08-15 | $17.00K derived: sum of 3 quarters · filed 2022-08-15 | $19.00K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $11.00K 10-Q · filed 2022-05-16 | $10.00K derived: sum of 2 quarters · filed 2022-05-16 | $12.00K derived: sum of 3 quarters · filed 2022-05-16 | $79.00K derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $1.00K derived: sum of 2 quarters · filed 2022-04-08 | $68.00K derived: sum of 3 quarters · filed 2022-04-08 | $238.00K 10-K · filed 2022-04-08 | ||
| 2020-09-30 | $2.00K 10-Q · filed 2021-11-15 | $69.00K derived: sum of 2 quarters · filed 2021-11-15 | $239.00K 10-Q · filed 2021-11-15 | $343.00K derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $67.00K 10-Q · filed 2021-08-16 | $66.75K 10-Q · filed 2020-08-10 | $238.00K 10-Q · filed 2021-08-16 | $237.83K 10-Q · filed 2020-08-10 | $341.00K derived: sum of 3 quarters · filed 2021-08-16 | $438.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $171.00K 10-Q · filed 2021-05-17 | $171.08K 10-Q · filed 2020-05-11 | $274.00K derived: sum of 2 quarters · filed 2021-05-17 | $371.00K derived: sum of 3 quarters · filed 2021-05-17 | $445.48K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $200.00K derived: sum of 2 quarters · filed 2021-03-31 | $274.48K derived: sum of 3 quarters · filed 2021-03-31 | $392.00K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $97.00K 10-Q · filed 2020-11-09 | $171.48K derived: sum of 2 quarters · filed 2020-11-09 | $289.00K 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $74.48K 10-Q · filed 2020-08-10 | $192.00K 10-Q · filed 2020-08-10 | ||||
| 2019-03-31 | $117.53K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |